Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT05229380 |
Other study ID # |
DEmadtympanoplasty |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
February 28, 2022 |
Est. completion date |
January 31, 2023 |
Study information
Verified date |
January 2022 |
Source |
Assiut University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The eustachian tube (ET) performs three primary functions: pressure equalisation between the
nasopharyms and middle ear: clearance of mucus from the middle ear, and prevention of sound
or fluid reflux from the nasopharynx(1) .In individuals suffering from custachian tube
dysunction (ETD), the tube opening may be obstructed(2) resulting in the typical complaints
of ear fullness, muffled hearing, or tinnitus(3). Less frequently, the ET may be permanently
patulous, resulting in the symptoms of aural pressure or autophony (4). Adequate Eustachian
tube function (ETF) is necessary for successful middle ear surgery. Studies of eustachian
tube patency have been studied by the Politzer, Valsalva, and Toynbee maneuvers. In other
cases it has been accomplished by testing air transport through the eustachian tube by
tympanometry, sonotubometry, and air pressure equalization technique. However, these methods
do not evaluate the drainage function (5). Saccharin is a nonnutritive sweetener. It has
property of being inert to respiratory epithelium that is it does not hamper physiological
mucus clearance of sino-nasal mucosa. It can be used to assess mucocilliary function of nasal
mucosa, without itself hampering it. The saccharin test seems to provide adequate information
of the mucociliary function and patency of the ET (6) . Methylene blue is a chemical
compound. It can be used to check patency of (ET). The dye, because of its liquid form,
gravitates through the ET to the nasopharynx. So the objective of the dye is to establish the
anatomical presence or absence of tube patency.
Description:
1. Full history taking, general and Complete otolaryngology examination to ride at any
pathologies and focus of infection which could influence the result of tympanoplasty.
2. Audiological evaluation will be done for all patients both preoperatively and
postoperatively
3. Computed Tomography scanning of the mastoids will be done for all cases to rule out
mastoiditis of any type
4. Otoscopic examination size and site of perforation will be noted. The condition of
middle ear mucosa, annulus, handle of malleus, and remnant of tympanic membrane (TM)
will also be noted.
5. Diagnostic Nasal Endoscopy: detailed nasal examination will be carried out. The nasal
findings and the condition of the ET orifice will be noted.
6. Saccharin test : Within two weeks before the surgery, the test will be performed. First,
the taste response of patient to saccharin solution will br tested. With the patient
seated and head tilted to the other ear , two drop of sterile sweety saccharin solution
(one teaspoon saccharin granules dissolved in 10 ml sterile water) will placed in the
middle ear through the TM defect by a dropper. The time required for the patient to
taste the saccharin (ie, saccharin perception time [SPT]) will then measured.
7. Methylene Blue Test: Within two weeks before the surgery, the test will be performed.
The nose is first prepared by applying a nasal pack soaked in a solution composed of
mixture of xylometazoline hydrchloride 0.1% and xylocaine 10% (1:1) for 10 minutes. Then
0- degree sinscope (Karl storz, Germany) will passed through the nose till an adequate
view of the nasopharyngeal opening of the ET is obtained. Two to three drops of sterile
methylene blue dye will placed in the middle ear through the TM defect after tilting the
patients head towards the opposite ear.
8. Within a week of evaluation of ETF, patients will be operated on for type 1
tympanoplasty after 3 weeks patients are reviewed for inspection of the operated ear.
The second and third postoperative reviews will be done at 2 months and 6 months,
respectively Patients were evaluated postoperatively by otoscopy, tympanometry, and
audiometry.